Dr. Neera Kanhouwa Dahl, MD

Dr. Dahl practices at Mayo Clinic Breast Diagnostic Clinic in Rochester, Minnesota.

Dr. Dahl's NPI, 1336254002, was assigned on August 20, 2006. Dr. Dahl graduated from Tufts University School Of Medicine in 1993. Dr. Dahl holds Minnesota license 72916.

Dr. Dahl's primary practice is Mayo Clinic Breast Diagnostic Clinic, at 200 First Street SW, Rochester, MN 55905. The practice phone is (507) 284-5968.

Dr. Dahl's primary practice is Mayo Clinic Breast Diagnostic Clinic in Rochester, Minnesota. Dr. Dahl is also affiliated with Mayo Clinic Hospital, Saint Marys Campus. The medical group on file is Mayo Clinic. Dmand AI also links Dr. Dahl to 1 more clinical lab and 1 hospice, each named with a free account. Dr. Dahl's employer is on file too: a breast imaging center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dahl practices, 4 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Dahl's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Dahl is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Dahl's licenses on file in 4 states: Minnesota, Connecticut, New York and Massachusetts.

Dmand AI lists acute kidney failure, chronic anemia, chronic kidney disease, hypercalcemia, kidney cysts, kidney disease and kidney failure among the conditions Dr. Dahl treats.

CMS data shows 325 Medicare services from Dr. Dahl across 9 procedure codes in 2024, for 208 Medicare patients. Medicare paid $20,304 for them.

CMS counts 208 Medicare patients who saw Dr. Dahl in 2024. The largest group is 65 to 74, with 88 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 13% are also on Medicaid. Their average risk score is 2.89, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Dahl's median patient age at 63, with 53% women.

In 2024, Dr. Dahl wrote 268 Medicare Part D claims for 68 patients. 90% of them were for generic drugs. CMS names the drug for 176 of them, across 8 drugs with 11 or more claims each, at $15,924 in total drug cost. In 2023, CMS named 177 claims across 8 drugs.

Dr. Dahl accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Dahl as offering telehealth.

Dmand AI links 65 papers to Dr. Dahl, published from 2011 to 2025. 2023 was the busiest year, with 8. The most frequent topics are Polycystic Kidney, Autosomal Dominant, Kidney and Genetic Testing. Dr. Dahl has published most often in Kidney360. Dr. Dahl's most frequent co-authors are Fouad Chebib, MD, Vicente E. Torres, MD and Ashima Gulati, MD.

Dmand AI links Dr. Dahl to 4 clinical trials. Conditions studied include Polycystic Kidney, Autosomal Dominant and Polycystic Kidney Diseases.

CMS Open Payments shows 143 general payments to Dr. Dahl from 13 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 75% of the total. Otsuka America Pharmaceutical, Inc. paid the most, $61,078. It also lists 1 research payment totaling $325 in 2021.

Dmand AI lists 2 awards for Dr. Dahl, most recently Top Doctors: New York Metro Area in 2014.

Dr. Dahl graduated from Tufts University School Of Medicine in 1993.

Dr. Dahl is in network with 18 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.